Regulation and privilege in transplantation tolerance.
BACKGROUND
There are now many ways of achieving transplantation tolerance in rodents that do not require stem cell chimerism. The best studied of these utilize short courses of antibody treatment aimed at blocking the co-receptors CD4 and CD8, and/or co-stimulatory molecules such as CD40L. Unlike tolerance through mixed chimerism which can be absolute, this form of tolerance is operational with potential effector cells remaining, but under the control of CD4 regulatory T cells (Treg). Both natural and induced CD4(+)CD25(+) FoxP3(+) Treg are involved, although other categories of Treg may also participate. Tolerated grafts can be shown to contain Treg cells, and we have proposed that they function within the graft and draining lymphoid tissue to generate a state of acquired privilege.


CONCLUSIONS
The finding of linked suppression in tolerance suggests that Treg are drawn into microenvironments where they decommission antigen-presenting cells, and consequently perpetuate more regulation through conversion of naive T cells to regulators. Persistent antigen from accepted transplants operating within such inhibitory microenvironments provides the basis for infectious tolerance through the life of the recipient. Regulation may operate at any stage of the rejection response. Induction of tolerance appears to involve a role for the cytokine TGFbeta. This may operate both to convert naive T cells to Treg function while also subverting effector functions necessary for rejection.
Waldmann
Herman
H
Sir William Dunn School of Pathology, South Parks Road, Oxford, OX1 3RE, UK. herman.waldmann@path.ox.ac.uk
Adams
Elizabeth
E
Fairchild
Paul
P
Cobbold
Stephen
S
D000818:Animals; D000938:Antigen-Presenting Cells / Q000276:immunology; D016207:Cytokines / Q000276:immunology; D006084:Graft Rejection / Q000276:immunology / Q000517:prevention & control*; D006085:Graft Survival / Q000276:immunology; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D050378:T-Lymphocytes, Regulatory / Q000276:immunology*; D016212:Transforming Growth Factor beta / Q000276:immunology; D023001:Transplantation Tolerance / Q000276:immunology*
D016207:Cytokines; D016212:Transforming Growth Factor beta
J Exp Med. 2005 Apr 4;201(7):1037-44
15809349
J Immunol. 1996 May 15;156(10):3602-7
8621893
J Exp Med. 2004 May 17;199(10):1401-8
15148338
Immunol Rev. 2006 Oct;213:239-55
16972908
Immunol Rev. 2001 Aug;182:164-79
11722632
Nature. 1953 Oct 3;172(4379):603-6
13099277
Semin Immunol. 2006 Apr;18(2):111-9
16476553
Transplantation. 2005 Mar 27;79(6):648-54
15785370
Am J Transplant. 2006 Sep;6(9):2121-33
16796719
Transplantation. 1996 Nov 15;62(9):1200-6
8932256
Eur J Immunol. 1990 Dec;20(12):2737-45
1702726
Nat Immunol. 2003 Apr;4(4):337-42
12612581
J Exp Med. 2007 Jun 11;204(6):1257-65
17502665
Immunol Rev. 2002 Jul;185:227-35
12190934
Science. 2003 Feb 14;299(5609):1057-61
12522256
J Immunol. 1998 Dec 1;161(11):5813-6
9834057
J Exp Med. 2002 Jun 17;195(12):1641-6
12070291
Immunol Rev. 2006 Aug;212:301-13
16903922
J Exp Med. 1998 Jul 20;188(2):287-96
9670041
Semin Immunol. 2003 Aug;15(4):209-14
14690045
J Exp Med. 1989 Mar 1;169(3):779-94
2647894
J Immunol. 2004 May 15;172(10):6003-10
15128783
Blood. 2007 Mar 1;109(5):2058-65
17110462
Nature. 2006 Aug 31;442(7106):997-1002
16921386
Nature. 1986 Apr 3-9;320(6061):449-51
2938014
Proc Natl Acad Sci U S A. 2004 Jul 6;101(27):10122-6
15218097
Science. 1993 Feb 12;259(5097):974-7
8094901
Nat Immunol. 2003 Apr;4(4):330-6
12612578
Immunol Rev. 2001 Aug;182:201-6
11722635
Transpl Immunol. 2003 Jul-Sep;11(3-4):235-44
12967777
Transplantation. 1996 Dec 15;62(11):1614-21
8970617
J Immunol. 1996 Jul 15;157(2):529-33
8752898
Curr Opin Immunol. 2000 Dec;12(6):676-83
11102772
J Immunol. 1998 Mar 15;160(6):2645-8
9510162
J Clin Invest. 2004 Jun;113(12):1754-62
15199410
J Immunol. 1998 Aug 15;161(4):1868-74
9712055
J Exp Med. 1985 Nov 1;162(5):1683-94
2932519
Am J Transplant. 2007 Apr;7(4):914-22
17286616
J Exp Med. 2005 Jun 20;201(12):1925-35
15967822
Immunology. 1971 Dec;21(6):903-14
4943147
Transplantation. 1997 Jun 15;63(11):1570-3
9197347
Nat Med. 2004 Sep;10(9):942-9
15322536
J Immunol. 2002 Feb 1;168(3):1069-79
11801640
J Immunol. 2002 Jun 1;168(11):5558-65
12023351
Transplantation. 2006 Jul 15;82(1):23-9
16861937
Exp Hematol. 2006 Jan;34(1):66-71
16413392
J Autoimmun. 1992 Apr;5 Suppl A:93-102
1503639
Nature. 1997 Oct 16;389(6652):737-42
9338786
J Immunol. 2000 Nov 1;165(9):4783-6
11045999
N Engl J Med. 2005 Dec 1;353(22):2342-51
16319383
J Immunol. 2004 May 1;172(9):5213-21
15100259
J Immunol. 2003 Aug 15;171(4):1652-5
12902462
Eur J Immunol. 1994 Oct;24(10):2383-92
7925565
J Immunol. 2007 Oct 1;179(7):4901-9
17878390
Int Immunol. 2004 Oct;16(10):1391-401
15351783
Immunol Rev. 1996 Feb;149:5-33
9005219
J Exp Med. 2003 Dec 15;198(12):1875-86
14676299
J Immunol. 1995 Aug 1;155(3):1151-64
7636184
Immunol Rev. 2003 Dec;196:109-24
14617201
Curr Opin Immunol. 2004 Dec;16(6):775-9
15511672
J Immunol. 2007 Sep 15;179(6):3648-54
17785800
J Immunol. 2002 Feb 1;168(3):1080-6
11801641
Nat Immunol. 2002 Dec;3(12):1208-13
12415266
Transplant Proc. 2006 Dec;38(10):3233-5
17175232
J Immunol. 1999 Nov 1;163(9):4805-10
10528180
Nat Rev Immunol. 2008 Jan;8(1):74-80
18064049
J Immunol. 2006 Apr 1;176(7):3915-22
16547225
J Immunol. 2007 Jul 15;179(2):967-76
17617588
Nature. 2007 Nov 22;450(7169):566-9
18033300
J Exp Med. 1990 Dec 1;172(6):1701-8
2258700
Blood. 2006 Feb 1;107(3):1018-23
16210336
Nat Immunol. 2003 Dec;4(12):1206-12
14578884
J Exp Med. 2003 Feb 17;197(4):451-60
12591903
Mol Ther. 2008 Jan;16(1):194-202
17984976